Showing results (301-310 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|December 16, 2017
Therapeutic Delivery of Simvastatin Loaded in PLA-PEG Polymersomes Resulted in Amplification of Anti-inflammatory Effects in Activated MicrogliaDharani Manickavasagam, Kimberly Novak, Moses O OyewumiThe AAPS Journal|September 7, 2017
Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case StudySumit K Singh, Deepak Kumar, Anurag S RathoreThe AAPS Journal|September 7, 2017
Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for EtodolacCarolina de Miranda Silva, Adriana Rocha, Eduardo Tozatto, et al.The AAPS Journal|September 15, 2017
Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug DevelopmentBeatriz Rodriguez-Grande, Aleksandra Ichkova, Sighild Lemarchant, et al.The AAPS Journal|September 13, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast AsiaJesmin Lohy Das, Arjen M Dondorp, Francois Nosten, et al.The AAPS Journal|February 14, 2018
Correction to: Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and SafetyJose Meseguer-Ripolles, Salman R Khetani, Javier G Blanco, et al.The AAPS Journal|February 28, 2018
New Perspectives in Clinical Pharmacokinetics-1: the Importance of Updating the Teaching in Pharmacokinetics that both Clearance and Elimination Rate Constant Approaches Are Mathematically Proven Equally ValidRoger Jelliffe, David BayardThe AAPS Journal|February 25, 2018
Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular CarcinomaChenxi Qu, Jizhao Li, Yejuan Zhou, et al.The AAPS Journal|March 9, 2018
Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.The AAPS Journal|February 9, 2018
Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical StudiesDanuta J Herzyk, Helen G HaggertyPageof 235